Integration of genomic and metabonomic data in systems biology - Are we 'there' yet?

Current Opinion in Drug Discovery and Development

Volumn 9, Issue 1, 2006, Pages 92-100

  Thomas, Craig E ^a   Ganji, Gopinath ^b  

^a ELI LILLY AND COMPANY   (United States)

^b Eli Lilly Singapore Pte Ltd   (Singapore)

Author keywords

Genomics; Metabonomics; Microarray; Pathways; Proteomics; Toxicology

Indexed keywords

DATA ANALYSIS; DATA BASE; DATA EXTRACTION; EXPOSURE; GAS CHROMATOGRAPHY; GENETIC ANALYSIS; GENOMICS; HUMAN; LEARNING; METABOLISM; METABOLITE; METABOLOMICS; METABONOMICS; NONHUMAN; PROTEIN ANALYSIS; PROTEOMICS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; STATISTICAL ANALYSIS; STRESS; SYSTEMS BIOLOGY;

ACETAMINOPHEN; ANIMALS; BIOLOGICAL MARKERS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOMICS; HUMANS; HYDRAZINES; LIVER; MODELS, BIOLOGICAL; OROTIC ACID; PROTEOMICS; SYSTEMS INTEGRATION;

EID: 30744463069     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Saglio G, Cilloni D, Rancati F, Boano L: Glivec and CML: A lucky date. J Biol Regul Homeostatic Agents (2004) 18(2):246-251.
2. Pognan F: Genomics, proteomics and metabonomics in toxicology: Hopefully not 'fashionomics'. Pharmacogenomics (2004) 5(7):879-893. Provides an extensive review of 'omics technologies, focusing on the strengths and weaknesses of each approach when used in isolation, and the opportunities, challenges and limitations associated with data integration as applied to toxicology.
3. Kell DB: Metabolomics and systems biology: Making sense of the soup. Curr Opin Microbiol (2004) 7(3):296-307. Provides a concise, informative review that highlights technical aspects, such as database building, which are critical for fully understanding the biological context of metabolome changes. Emphasis is placed on using modeling methods to reconstruct metabolic networks.
4. Gershon D: Proteomics technologies: Probing the proteome. Nature (2003) 424(6948):1581-587.
5. Liebler DC, Guengerich FP: Elucidating mechanisms of drug-induced toxicity. Nat Rev Drug Discov (2005) 4(5):410-420.
6. Lotze MT, Wang E, Marincola FM, Hanna N, Bugelski PJ, Burns CA, Coukos G, Damle N, Godfrey TE, Howell WM, Panelli MC et al: Workshop on cancer biometrics: Identifying biomarkers and surrogates of cancer in patients: A meeting held at the Masur auditorium, National Institutes of Health. J Immunother(2005) 28(2):79-119.
7. Urbanczyk-Wochniak E, Luedemann A, Kopka J, Selbig J, Roessner-Tunali U, Willmitzer L, Fernie AR: Parallel analysis of transcript and metabolic profiles: A new approach in systems biology. EMBO Rep (2003) 4(10):989-993. The potato tuber has clearly defined developmental stages and was used as a test system to compare transcript profiles and metabolites to distinguish between, and categorize, the different systems. Overall, dissociation of the developmental stages was more evident when measuring metabolites than gene expression. When pairwise transcript-metabolite correlation analysis was performed, several novel correlations between genes and metabolites were revealed.
8. Goodacre R: Making sense of the metabolome using evolutionary computation: Seeing the wood with the trees. J Exp Bot (2005) 56(410):245-254.
9. Fridman E, Pichersky E: Metabolomics, genomics, proteomics and the identification of enzymes and their substrates and products. Curr Opin Plant Biol (2005) 8(3):242-248.
10. Manetti C, Blanchetti C, Bizzarri M, Casciani L, Castro C, D'Ascenzo G, Delfini M, Di Cocco ME, Lagana A, Miccheli A, Motto M et al: NMR-based metabonomic study of transgenic maize. Phytochemistry (2004) 65(24):3187-3198. Describes one of the relatively few examples of using NMR, rather than MS, in the study of plant metabolites. The authors conclude that NMR is valuable as a tool for non-targeted analysis of metabolites, when coupled with multivariate statistical analyses.
11. Coen M, Ruepp SU, Lindon JC, Nicholson JK, Pognan F, Lenz EM, Wilson ID: Integrated application of transcriptomics and metabonomics yields new insight into the toxicity due to paracetamol in the mouse. J Pharm Biomed Anal (2004) 35(1):93-105.
12. Griffin JL, Bonney SA, Mann C, Hebbachi AM, Gibbons GF, Nicholson JK, Shoulders CC, Scott J: An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver. Physiol Genomics (2004) 17(2):140-149. Provides an excellent example of how genomic, proteomic and metabonomic data can be leveraged to provide a deeper, or more precise, knowledge of mechanism of action. In this case, it was clearly demonstrated that orotic acid affected the transcription of selected genes, which was corroborated by corresponding changes in metabolites.
13. Nicholson JK, Connelly J, Lindon JC, Holmes E: Metabonomics: A platform for studying drug toxicity and gene function. Nat Rev Drug Discov(2002) 1(2):153-161. One of the first publications to clearly articulate the temporal relationships between genes, proteins and metabolites as applied to toxicology and functional genomics.
14. KEGG: Kyoto encyclopedia of genes and genomes: Kanehisa Laboratories, Kyoto University, Kyoto, Japan, www.genome.jp/kegg
15. Kleno TG, Kiehr B, Baunsgaard D, Sidelmann UG: Combination of 'omics' data to investigate the mechanism(s) of hydrazine-induced hepatotoxicity in rats and to identify potential biomarkers. Biomarkers (2004) 9(2):116-138.
16. Mayr M, Mayr U, Chung YL, Yin X, Griffiths JR, Xu Q: Vascular proteomics: Linking proteomic and metabolomic changes. Proteomics (2004) 4(12):3751-3761.
17. Heijne WH, Stierum RH, Slijper M, van Bladeren PJ, van Ommen B: Toxicogenomics of bromobenzene hepatotoxictty: A combined transcriptomics and proteomics approach. Biochem Pharmacol (2003) 66(5):857-875.
18. Heijne WH, Lamers RJ, van Bladeren PJ, Groten JP, van Nesselrooij JH, van Ommen B: Profiles of metabolites and gene expression in rats with chemically induced hepatic necrosis. Toxicol Pathol (2005) 33(4):425-433. Describes an integrated toxicogenomics study analyzing bromobenzene-induced acute hepatotoxicity by measuring changes at transcript and NMR-derived metabolite levels at various times and doses. Interestingly, the authors report that plasma metabolomics was more sensitive in terms of yielding toxicity markers.
19. 1H nuclear magnetic resonance and high-performance liquid chromatography. Biomarkers (2003) 8(3-4):240-271.
20. Hirai MY, Yano M, Goodenowe DB, Kanaya S, Kimura T, Awazuhara M, Arita M, Fujiwara T, Saito K: Integration of transcriptomics and metabolomics for understanding of global responses to nutritional stresses in Arabidopsis thaliana. Proc Natl Acad Sci USA (2004) 101(27):10205-10210.
21. Lin B, White JT, Lu W, Xie T, Utleg AG, Yan X, Yi EC, Shannon P, Khrebtukova I, Lange PH, Goodlett DR et al: Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: A systems approach to disease. Cancer Res (2005) 65(8):3081-3091. Describes a recent study examining differences between androgen-sensitive and -insensitive prostate cancer cell lines by measuring mRNA changes by massive parallel signature sequencing and protein changes by ICAT® proteomics. The data were mapped to pathways to reveal perturbed networks reflecting disease progression.
22. Tohge T, Nishiyama Y, Hirai MY, Yano M, Nakajima J, Awazuhara M, Inoue E, Takahashi H, Goodenowe DB, Kitayama M, Noji M et al: Functional genomics by integrated analysis of metabolome and transcriptome of Arabidopsis plants over-expressing an MYB transcription factor. Plant J (2005) 42(2):218-235.
23. Ippolito JE, Xu J, Jain S, Moulder K, Mennerick S, Crowley JR, Townsend RR, Gordon JI: An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proc Natl Acad Sci USA (2005) 102(28):9901-9906. Describes an interesting and elegant approach to using gene expression-derived signatures to predict metabolites by in silico metabolic reconstructions of neuroendocrine cancer cell metabolism. Results yielded novel insights into disease etiology as well as prognostic markers.
24. Ippolito JE, Xu J, Jain S, Moulder K, Mennerick S, Crowley JR, Townsend RR, Gordon JI: METAVIEW: An integrated functional genomics and metabolomlcs approach for defining poor prognosis in human neuroendocrine cancers. Washington University in St Louis, St Louis, MO, USA. http://gordonlab.wustl.edu/metaview/ ippolito
25. Prokisch H, Scharfe C, Camp DG 2nd, Xiao W, David L, Andreoli C, Monroe ME, Moore RJ, Gritsenko MA, Kozany C, Hixson KK et al: Integrative analysis of the mitochondrial proteome in yeast PLoS Biol (2004) 2(6):e160.
26. Kriete A, Anderson MK, Love B, Freund J, Caffrey JJ, Young MB, Sendera TJ, Magnuson SR, Braughler JM: Combined histomorphometric and gene-expression profiling applied to toxicology. Genome Biol (2003) 4(5):R32.
27. Haugen AC, Kelly R, Collins JB, Tucker CJ, Deng C, Afshari CA, Brown JM, Ideker T, Van Houten B: Integrating phenotypic and expression profiles to map arsenic-response networks. Genome Biol (2004) 5(12):R95.
28. Begley TJ, Rosenbach AS, Ideker T, Samson LD: Hot spots for modulating toxicity identified by genomic phenotypilng and localization mapping. Mol Cell (2004) 16(1):117-125.
29. Jones GL, Sang E, Goddard C, Mortishire-Smith RJ, Sweatman BC, Haselden JN, Davies K, Grace AA, Clarke K, Griffin JL: A functional analysis of mouse models of cardiac disease through metabolic profiling. J Biol Chem (2005) 280(9):7530-7539. Discusses research which clearly demonstrates that heart tissue metabolite profiling is an effective means to phenotypically describe four separate models of cardiac disease in the mouse. Multivariate statistics allowed the dissociation of each disease model from its control strain.
30. Pathguide: The Pathway Resource List: Memorial Sloan-Kettering Cancer Center, New York, NY, USA. http://cbio.mskcc.org/prl/index.php
31. Arita M: Additional paper: Computational resources for metabolomics. Brief Fund Genomic Proteomic (2004) 3(1):84-93.
32. Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB: Metabolomics by numbers: Acquiring and understanding global metabolite data. Trends Biotechnol (2004) 22(5):245-252. Provides a highly readable review chapter that overviews the current status of metabolomics, with an emphasis on analytical methods and data analysis tools that are used to turn information into knowledge.
33. Curtis RK, Oresic M, Vidal-Puig A: Pathways to the analysis of microarray data. Trends Biotechnol (2005) 23(8):429-435. Presents a good overview of the current tools and methods available to group genes from a high-throughput experiment (eg, arrays) into statistically significant functional categories. Advantages and pitfalls of various popularly used approaches are presented.
34. Reactome - a knowledgebase of biological processes: Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA/European Bioinformatics Institute Heidelberg, Germany. http://www.reactome.org
35. Davidov E, Clish CB, Oresic M, Meys M, Stochaj W, Snell P, Lavine G, Londo TR, Adourian A, Zhang X, Johnston M et al: Methods for the differential integrative omic analysis of plasma from a transgenic disease animal model. OMICS (2004) 8(4):267-288.
36. Lelliott CJ, Lopez M, Curtis RK, Parker N, Laudes M, Yeo G, Jimenez-Linan M, Grosse J, Saha AK, Wiggins D, Hauton D et al: Transcript and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic Steatosis. FASEB J (2005) 19(9):1108-1119.
37. Verhoeckx KC, Bijlsma S, Jespersen S, Ramaker R, Verheij ER, Witkamp RF, van der Greef J, Rodenburg RJ: Characterization of anti-inflammatory compounds using transcriptomics, prateomics and metabolomics in combination with multivariate data analysis. Int Immunopharmacol (2004) 4(12):1499-1514. Provides an excellent example demonstrating the power of integrating microarrays, 2D gel electrophoresis and LC-MS-based lipid profiling in U937 macrophage cells (stimulated with lipopolysaccharide with or without compound) to characterize the effects of six anti-inflammatory compounds. PC-DA was used to integrate the various data types.
38. Mercke P, Kappers IF, Verstappen FW, Vorst O, Dicke M, Bouwmeester HJ: Combined transcript and metabolite analysis reveals genes involved in spider mite induced volatile formation in cucumber plants. Plant Physiol (2004) 136(4):2012-2024.
39. Hirai MY, Klein M, Fujikawa Y, Yano M, Goodenowe DB, Yamazaki Y, Kanaya S, Nakamura Y, Kitayama M, Suzuki H, Sakurai N et al: Elucidation of gene-to-gene and metabolite-to-gene networks in Arabidopsis by integration of metabolomics and transcriptomics. J Biol Chem (2005) 280(27):25590-25595.
40. Li Z, Chan C: Integrating gene expression and metabolic profiles. J Biol Chem (2004) 279(28):27124-27137. Provides a good illustration of a probabilistic technique, based on genetic algorithms and PLS, which can be used to integrate gene expression and metabolic flux data.
41. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA et al: A gene expression database for the molecular pharmacology of cancer. Nat Genet (2000) 24(3):236-244.
42. Butte AJ, Tamayo P, Slonim O, Golub TR, Kohane IS: Discovering functional relationships between RNA expression and chemothorapeutic susceptibility using relevance networks. Proc Natl Acad Sci USA (2000) 97(22):12182-12186.
43. Fung E, Wong WW, Suen JK, Bulter T, Lee SG, Liao JC: A synthetic gene-metabolic oscillator. Nature (2005) 436(7038):118-122. In this seminal piece of research, an artificial oscillatory circuit was constructed in Escherichia coli K12, called the metabolator, using glycolytic flux. The design principles are elucidated using non-linear dynamics and bifurcation analysis.
44. Bino RJ, Hall RD, Fiehn O, Kopka J, Saito K, Draper J, Nikolau BJ, Mendes P, Roessner-Tunali U, Beale MH, Trethewey RN et al: Potential of metabolomics as a functional genomics tool. Trends Plant Sci (2004) 9(9):418-425.
45. Lindon JC, Nicholson JK, Holmes E, Keun HC, Craig A, Pearce JT, Bruce SJ, Hardy N, Sansone SA, Antti H, Jonsson P et al: Summary recommendations for standardization and reporting of metabolic analyses. Nat Biotechnol (2005) 23(7):833-838.
46. Kell DB: Metabolomics, machine learning and modelling: Towards an understanding of the language of cells. Biochem Soc Trans (2005) 33(Pt 3):520-524. Review offering provocative thoughts regarding philosophical approaches to integrating biological endpoints into systems biology. An emphasis is placed on the concept that understanding of biological signaling pathways is not fully realized when measuring/focusing solely on absolute concentrations of pathway intermediates, but rather on how downstream elements are affected by dynamic changes.
47. Bilello JA: The agony and ecstasy of "OMIC" technologies in drug development. Curr Mol Med (2005) 5(1):39-52.
48. Lindon JC, Holmes E, Nicholson JK: Metabonomics and its role in drug development and disease diagnosis. Expert Rev Mol Diagnostics (2004) 4(2):189-199.
49. Griffin JL: Metabolic profiles to define the genome: Can we hear the phenotypes? Philos Trans R Soc Lond B-Biol Sci (2004) 359(1446):857-871.
50. 13C-labeling experiments and integration of the information with gene and protein expression patterns. Adv Biochem Eng Biotechnol (2004) 91:1-49.
51. Krishnan P, Kruger NJ, Ratcliffe RG: Metabolite fingerprinting and profiling in plants using NMR. J Exp Bot (2005) 56(410):255-265.
52. 1H NMR spectra of biofluids. Analyst (2002) 127(10):1283-1288.
53. Clayton TA, Lindon JC, Everett JR, Charuel C, Hanton G, Le Net JL, Provost JP, Nicholson JK: Hepatotoxin-induced hypercreatinaemia and hypercreatinuria: Their relationship to one another, to liver damage and to weakened nutritional status. Arch Toxicol (2004) 78(2):86-96.
54. Nicholson JK, Holmes E, Wilson ID: Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol (2005) 3(5):431-438. Describes advances in analytical techniques and data analysis that permitted the detection and identification of greater numbers of metabolites than ever before. Accordingly, it becomes even more imperative to understand the implications or relevance of the findings. How gut microflora can profoundly affect the response of an organism to nutrition and drugs, and hence the metabolic profile, are also discussed.